351 related articles for article (PubMed ID: 15940367)
1. Overexpression of human PHEX under the human beta-actin promoter does not fully rescue the Hyp mouse phenotype.
Erben RG; Mayer D; Weber K; Jonsson K; Jüppner H; Lanske B
J Bone Miner Res; 2005 Jul; 20(7):1149-60. PubMed ID: 15940367
[TBL] [Abstract][Full Text] [Related]
2. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.
Sitara D; Razzaque MS; Hesse M; Yoganathan S; Taguchi T; Erben RG; Jüppner H; Lanske B
Matrix Biol; 2004 Nov; 23(7):421-32. PubMed ID: 15579309
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype.
Liu S; Guo R; Tu Q; Quarles LD
J Biol Chem; 2002 Feb; 277(5):3686-97. PubMed ID: 11713245
[TBL] [Abstract][Full Text] [Related]
4. New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice.
Lorenz-Depiereux B; Guido VE; Johnson KR; Zheng QY; Gagnon LH; Bauschatz JD; Davisson MT; Washburn LL; Donahue LR; Strom TM; Eicher EM
Mamm Genome; 2004 Mar; 15(3):151-61. PubMed ID: 15029877
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
6. Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression.
Bai X; Miao D; Panda D; Grady S; McKee MD; Goltzman D; Karaplis AC
Mol Endocrinol; 2002 Dec; 16(12):2913-25. PubMed ID: 12456809
[TBL] [Abstract][Full Text] [Related]
7. Coordinated maturational regulation of PHEX and renal phosphate transport inhibitory activity: evidence for the pathophysiological role of PHEX in X-linked hypophosphatemia.
Nesbitt T; Fujiwara I; Thomas R; Xiao ZS; Quarles LD; Drezner MK
J Bone Miner Res; 1999 Dec; 14(12):2027-35. PubMed ID: 10620061
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
Martin A; David V; Li H; Dai B; Feng JQ; Quarles LD
Mol Endocrinol; 2012 Nov; 26(11):1883-95. PubMed ID: 22930691
[TBL] [Abstract][Full Text] [Related]
9. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.
Yuan B; Takaiwa M; Clemens TL; Feng JQ; Kumar R; Rowe PS; Xie Y; Drezner MK
J Clin Invest; 2008 Feb; 118(2):722-34. PubMed ID: 18172553
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia.
Barros NM; Hoac B; Neves RL; Addison WN; Assis DM; Murshed M; Carmona AK; McKee MD
J Bone Miner Res; 2013 Mar; 28(3):688-99. PubMed ID: 22991293
[TBL] [Abstract][Full Text] [Related]
11. Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers.
Ruchon AF; Tenenhouse HS; Marcinkiewicz M; Siegfried G; Aubin JE; DesGroseillers L; Crine P; Boileau G
J Bone Miner Res; 2000 Aug; 15(8):1440-50. PubMed ID: 10934642
[TBL] [Abstract][Full Text] [Related]
12. Eldecalcitol Causes FGF23 Resistance for Pi Reabsorption and Improves Rachitic Bone Phenotypes in the Male Hyp Mouse.
Kaneko I; Segawa H; Ikuta K; Hanazaki A; Fujii T; Tatsumi S; Kido S; Hasegawa T; Amizuka N; Saito H; Miyamoto KI
Endocrinology; 2018 Jul; 159(7):2741-2758. PubMed ID: 29878089
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of Fgf23 in Hyp mice.
Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
[TBL] [Abstract][Full Text] [Related]
14. The effects of bone marrow transplantation on X-linked hypophosphatemic mice.
Miyamura T; Tanaka H; Inoue M; Ichinose Y; Seino Y
J Bone Miner Res; 2000 Aug; 15(8):1451-8. PubMed ID: 10934643
[TBL] [Abstract][Full Text] [Related]
15. The PHEX transgene corrects mineralization defects in 9-month-old hypophosphatemic mice.
Boskey A; Frank A; Fujimoto Y; Spevak L; Verdelis K; Ellis B; Troiano N; Philbrick W; Carpenter T
Calcif Tissue Int; 2009 Feb; 84(2):126-37. PubMed ID: 19082853
[TBL] [Abstract][Full Text] [Related]
16. A novel Phex mutation in a new mouse model of hypophosphatemic rickets.
Owen C; Chen F; Flenniken AM; Osborne LR; Ichikawa S; Adamson SL; Rossant J; Aubin JE
J Cell Biochem; 2012 Jul; 113(7):2432-41. PubMed ID: 22573557
[TBL] [Abstract][Full Text] [Related]
17. Dentoalveolar Defects in the
Zhang H; Chavez MB; Kolli TN; Tan MH; Fong H; Chu EY; Li Y; Ren X; Watanabe K; Kim DG; Foster BL
J Dent Res; 2020 Apr; 99(4):419-428. PubMed ID: 31977267
[TBL] [Abstract][Full Text] [Related]
18. PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia.
Blydt-Hansen TD; Tenenhouse HS; Goodyer P
Pediatr Nephrol; 1999 Sep; 13(7):607-11. PubMed ID: 10460513
[TBL] [Abstract][Full Text] [Related]
19. Increased cathepsin D release by Hyp mouse osteoblast cells.
Matsumoto N; Jo OD; Shih RN; Brochmann EJ; Murray SS; Hong V; Yanagawa J; Yanagawa N
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E123-32. PubMed ID: 15958652
[TBL] [Abstract][Full Text] [Related]
20. FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6.
Uchihashi K; Nakatani T; Goetz R; Mohammadi M; He X; Razzaque MS
Contrib Nephrol; 2013; 180():124-37. PubMed ID: 23652555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
